Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix: Potential role of PACE4 in the activation of proproteins in the extracellular matrix

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1645, Issue 1, 2003, Pages 95-104

  Tsuji, Akihiko ^a   Sakurai, Kensuke ^a   Kiyokage, Emi ^a   Yamazaki, Takahito ^a   Koide, Sizuyo ^a   Toida, Kazunori ^b   Ishimura, Kazunori ^b   Matsuda, Yoshiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bone morphogenetic protein; Extracellular matrix; Heparin; PACE4; Proprotein convertase; Proteoglycan

Indexed keywords

AMINO ACID; CATION; FURIN; HEPARIN; HEPARIN BINDING PROTEIN; ISOENZYME; SECRETORY PROTEIN; PCSK6 PROTEIN, HUMAN; PROPROTEIN CONVERTASE 5; PROTEOHEPARAN SULFATE; SERINE PROTEINASE; SUBTILISIN;

ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; EXTRACELLULAR FLUID; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PLACENTA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SOLUBILITY; STEREOCHEMISTRY; SYNCYTIOTROPHOBLAST; AMINO ACID SEQUENCE; BINDING SITE; CHEMISTRY; COMPARATIVE STUDY; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; TROPHOBLAST;

AMINO ACID SEQUENCE; BINDING SITES; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; PLACENTA; PROPROTEIN CONVERTASE 5; PROPROTEIN CONVERTASES; SERINE ENDOPEPTIDASES; SUBTILISINS; TROPHOBLASTS;

EID: 0037474206     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(02)00532-0     Document Type: Article

References (57)

1. Constam D.B., Robertson E.J. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertase. J. Cell Biol. 144:1999;139-149.
2. Aono A., Hazama M., Notoya K., Taketomi S., Yamasaki H., Tsukuda R., Sasaki S., Fujisawa Y. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem. Biophys. Res. Commun. 210:1995;670-677.
3. Mason A.J., Farnworth P.G., Sullivan J. Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A. Mol. Endocrinol. 10:1996;1055-1065.
4. Nakayama K. Furin: a mammalian subtilisin/kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327:1997;625-635.
5. Halban P.A., Irminger J.-C. Sorting and processing of secretory proteins. Biochem. J. 299:1994;1-18.
6. Dubois C.M., Laprise M.-H., Blanchette F., Gentry L.E., Leduc R. Processing of transforming growth factor β1 precursor by human furin convertase. J. Biol. Chem. 270:1995;10618-10624.
7. Constam D.B., Robertson E. Tissue-specific requirements for the proprotein convertase furin/SPC1 during embryonic turning and heart looping. Development. 127:2000;245-254.
8. Constam D.B., Robertson E.J. SPC4/PACE4 regulates TGFβ signaling network during axis formation. Genes Dev. 14:2000;1146-1155.
9. Nagahama M., Taniguchi T., Hashimoto E., Imamaki A., Mori K., Tsuji A., Matsuda Y. Biosynthetic processing and quaternary interactions of proprotein convertase SPC4 (PACE4). FEBS Lett. 434:1998;155-159.
10. Taniguchi T., Sakurai K., Kuroda R., Nagahama M., Wada I., Tsuji A., Matsuda Y. A critical role of the carboxy terminal region of proprotein convertase, PACE4A in the regulation of its autocatalytic activation coupled with the secretion. Biochem. Biophys. Res. Commun. 290:2002;878-884.
11. Nakagawa T., Hosaka M., Torii S., Watanabe T., Murakami K., Nakayama K. Identification and functional expression of a new member of the mammalian Kex2-like processing endoprotease family: its striking structural similarity to PACE4. J. Biochem. 113:1993;132-135.
12. Tsuji A., Hashimoto E., Ikoma T., Taniguchi T., Mori K., Nagahama M., Matsuda Y. Inactivation of proprotein convertase, PACE4, by α1- antitrypsin Portland (α1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: evidence that PACE4 is able to form an SDS-stable acyl intermediate with α1-PDX. J. Biochem. 126:1999;591-603.
13. Tsuji A., Yoshida S., Hasegawa S., Bando M., Yoshida I., Koide S., Mori K., Matsuda Y. Human subtilisin-like proprotein convertase, PACE4 (SPC4) gene expression is highly regulated through E-Box elements in HepG2 and GH4C1 cells. J. Biochem. 126:1999;494-502.
14. Dong W., Marcinkiewicz M., Vieau D., Chrétien M., Seidah N.G., Day R. Distinct mRNA expression of the highly homologous convertases PC5 and PACE4 in the rat brain and pituitary. J. Neurosci. 15:1995;1778-1796.
15. Yoshida I., Koide S., Hasegawa S., Nakagawara A., Tsuji A., Matsuda Y. Proprotein convertase PACE4 is down-regulated by the basic helix-loop-helix transcription factor hASH-1 and MASH-1. Biochem. J. 360:2001;683-689.
16. Cui Y., Jean F., Thomas G., Christian J.L. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryogenic development. EMBO J. 17:1998;4735-4743.
17. Akamatsu T., Matsuda Y., Tsumura K., Tada J., Parvin M.N., Kanamori N., Hosoi K. Subtilisin-like proprotein convertase PACE4 (SPC4) is a candidate processing enzyme of bone morphogenetic proteins during tooth formation. Dev. Dyn. 216:1999;481-488.
18. Akamatsu T., Matsuda Y., Tsumura K., Tada J., Parvin M.H., Wei W., Kanamori N., Hosoi K. Highly regulated expression of subtilisin-like proprotein convertase PACE4 (SPC4) during dentinogenesis. Biochem. Biophys. Res. Commun. 272:2000;410-415.
19. Constam D.B., Calfon M., Robertson E.J. SPC4, SPC6, and the novel protease SPC7 are coexpressed with bone morphogenetic proteins at distinct sites during embryogenesis. J. Cell Biol. 134:1996;181-191.
20. Huylebroeck D., Van Niemmen K., Waheed A., Von Figura K., Marmenout A., Fransen L., De Waele P., Jasper J.-M., Franchimont P., Stunnenberg H., Van Heuverswijn H. Expression and processing of the activin A/erythroid differentiation factor precursor: a member of the transforming growth factor-β superfamily. Mol. Endocrinol. 4:1990;1153-1165.
21. Wang E.A., Josephine V.R., Bauduy D.M., Cordes P., Harada T., Israel D.I., Hewick R.M., Kerns K.M., Lapan P., Luxengerg D.P., McQuaid D., Moutsatsos I.K., Nove J., Wozney J.M. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. U. S. A. 87:1990;2220-2224.
22. Bernfield M., Guötte M., Park W.P., Reizers O., Fitzgerald M.L., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Ann. Rev. Biochem. 68:1998;729-777.
23. Reddi A.H. Morphogenetic messages are in extracellular matrix: biochemistry from bench to bedside. Biochem. Soc. Trans. 28:2000;345-349.
24. Schmidt J.E., Suzuki A., Ueno N., Kimelman D. Localized BMP-4 mediates dorsal/ventral patterning in the early Xenopus embryo. Dev. Biol. 169:1995;37-50.
25. Jones C.M., Smith J.C. Establishment of a BMP-4 morphogen gradient by long-range inhibition. Dev. Biol. 194:1998;12-17.
26. Paine-Saunders S., Viviano B.L., Zupicich J., Skarnes W., Saunders S. Glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Dev. Biol. 225:2000;179-187.
27. Paine-Saunders S., Viviano B.L., Econemides A.N., Saunders S. Heparan sulfate proteoglycans retain noggin at the cell surface: a potential mechanism for shaping BMP gradients. J. Biol. Chem. 277:2001;2089-2096.
28. Hubbard F.C., Goodrow T.L., Liu S.-C., Brilliant M.H., Basset P., Mains R.E., Klein-Szanto A.J.P. Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability. Cancer Res. 57:1997;5226-5231.
29. Divid G. Integral membrane heparan sulfate proteoglycans. FASEB J. 7:1993;1023-1030.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
31. Novikova E.G., Reznik S.E., Varlamov O., Fricker L.D. Carboxypeptidase Z is present in the regulated secretory pathway and extracellular matrix in cultured cells and in human tissues. J. Biol. Chem. 275:2000;4865-4870.
32. Niquet J., Perez-Martinez L., Guerra M., Grouselle D., Joseph-Bravo P., Charli J.-L. Extracellular matrix proteins increase the expression of pro-TRH and pro-protein convertase PC1 in fetal hypothalamic neurons in vivo. Dev. Brain Res. 120:2000;49-56.
33. Nagamune H., Muramatsu K., Akamatsu T., Tamai Y., Izumi K., Tsuji A., Matsuda Y. Distribution of the kexin family proteases in pancreatic islets: PACE4C is specifically expressed in B cells of pancreatic islets. Endocrinology. 136:1995;357-360.
34. Akamatsu T., Daikoku S., Nagamune H., Yoshida S., Mori K., Tsuji A., Matsuda Y. Developmental expression of a novel kexin-family protease, PACE4E, in the rat olfactory system. Histochem. Cell Biol. 108:1997;95-103.
35. Wong P., Hampton B., Szylobryt E., Gallagher A.M., Jaye M., Burgess W.H. Analysis of putative heparin-binding domains of fibroblast growth factor: 1. Using site-directed mutagenesis and peptide analogues. J. Biol. Chem. 270:1995;25805-25811.
36. Tsuji A., Ikoma I., Hashimoto E., Matsuda Y. Development of selectivity of α1-antitrypsin variant by mutagenesis in its reactive site loop against proprotein convertase. A crucial role of the P4 arginine in PACE4 inhibition. Protein Eng. 15:2002;123-130.
37. Jean F., Stella K., Thomas L., Liu G., Xiang Y., Reason A.J., Thomas G. α1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc. Natl. Acad. Sci. U. S. A. 95:1998;7293-7298.
38. Wada I., Rindress D., Cameron P.H., Ou W.-J., Doherty J.J. II, Louvard D., Bell A.W., Dignard D., Thomas D.Y., Bergeron J.J.M. SSRa and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J. Biol. Chem. 266:1991;19559-19610.
39. Kassenbrock C.K., Kelly R.B. Interaction of heavy chain binding protein (BIP/GRP78) with adenine nucleotides. EMBO J. 8:1989;1461-1467.
40. Tsuji A., Hine C., Tamai Y., Yonemoto K., Mori K., Yoshida S., Bando M., Sakai E., Mori K., Akamatsu K., Matsuda Y. Genomic organization and alternative splicing of human PACE4 (SPC4), kexin-like processing endoprotease. J. Biochem. 122:1997;438-452.
41. Bando M., Matsuoka A., Tsuji A., Matsuda Y. The proprotein convertase PACE4 is upregulated by PDGF-BB in megakaryocytes: gene expression of PACE4 and furin is regulated differently in Dami cells. J. Biochem. 132:2002;127-134.
42. Bassi D.E., De Cicco R.L., Mahloogi H., Zucker S., Thomas G., Klein-Szanto A.J.P. Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10326-10331.
43. Khatib A.-M., Siegfried G., Prat A., Luis J., Chretien M., Metrakos P., Seidah N.G. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells. J. Biol. Chem. 276:2001;30686-30693.
44. Kuno K., Matsushima K. ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type I motifs and its splicing. J. Biol. Chem. 273:1998;13912-13917.
45. Novikova E., Fricker L.D. Purification and characterization of human metallocarboxypeptidase Z. Biochem. Biophys. Res. Commun. 256:1999;564-568.
46. Jokimma V., Inki P., Kujari H., Hirvonen O., Ekholm E., Anttila L. Expression of syndecan-1 in human placenta and decidua. Placenta. 19:1998;157-163.
47. Khan S., Blackburn M., Mao D.L., Huber R., Schlessinger D., Fant M. Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast. Histol. Histopathol. 16:2001;71-78.
48. Woessner J.F. Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
49. Takino T., Sato H., Shinagawa A., Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J. Biol. Chem. 270:1995;23013-23020.
50. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378:1997;151-160.
51. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:2001;463-516.
52. Pei D., Majmudar G., Weiss S.J. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269:1994;25849-25855.
53. Davis V., Persidskaia R., Baca-Regan L., Itoh Y., Nagase H., Persidsky Y., Ghorpade A., Baxter B.T. Matrix metalloprotease-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 18:1998;1625-1633.
54. 2+ for fibronectin and heparin binding. J. Biol. Chem. 272:1997;7473-7481.
55. Yu W.-H., Woessner J.F. Jr. Heparin sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloprotease 7). J. Biol. Chem. 275:2000;4183-4191.
56. Mahloogi H., Bassi D.E., Klein-Szanto A.J.P. Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4. Carcinogenesis. 23:2002;565-572.
57. Loo B.-M., Kreuger J., Jalkanen M., Lindahl U., Salmivirta M. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. J. Biol. Chem. 276:2001;16868-16876.